Pain control after third molar surgery
- PMID: 6150903
- DOI: 10.1016/s0300-9785(84)80017-4
Pain control after third molar surgery
Abstract
The ideal agent for use after third molar surgery should alleviate pain, reduce swelling and trismus to a minimum, promote healing and have no unwanted effects. Of course, such an agent does not exist. For relief of pain, analgesics are the obvious choice. Where possible, an analgesic with additional anti-inflammatory properties should be used. There seems little to choose between aspirin, 1000 mg; diflunisal, 500 mg; ibuprofen, 400 mg and zomepirac sodium, 50 mg. In the subject allergic to aspirin and aspirin-like compounds, then paracetamol is the poor alternative. Surprisingly, the efficacy of most of the opioids in post-operative third molar pain is poor, and these drugs alone cannot be recommended for this purpose. Long-acting local anaesthetic solutions may be of value in some situations where extreme pain is likely to be a feature in the immediate post-operative period. However, there are no strict criteria for identifying such cases pre-operatively. Recent work on the use of corticosteroids would suggest that these drugs may be of value in reducing post-operative sequelae. Their future in dentistry in this rôle appears interesting and promising, and worthy of further study. Antihistamines and enzymes have been shown to be of little value, and the fact that these agents now receive little attention is evidence in its own right. The use of locally applied antimicrobials has been shown to be of little value in third molar surgery. In any case, their use is probably contraindicated because of the risk of sensitising the patient. The studies reviewed have not pointed to the effectiveness of the routine use of systemic antimicrobials in preventing or reducing postoperative sequelae after removal of impacted third molars in normal circumstances. Particular conditions, for example in patients susceptible to infection, may benefit by the use of prophylactic antimicrobials. However, each case must be judged on its individual merits, bearing in mind the attendant risks inherent in antimicrobial therapy. Finally, whatever agent is chosen for the control of the post-operative sequelae after third molar surgery, it must be borne in mind that, if the normal post-operative course occurs, then treatment is unlikely to extend beyond 48 h. Few doses of the particular agent will hence be used during this time period and thus the incidence of unwanted effects will be minimised.
Similar articles
-
The use of third molar surgery in clinical pharmacology.Br J Oral Maxillofac Surg. 1993 Dec;31(6):360-5. doi: 10.1016/0266-4356(93)90191-x. Br J Oral Maxillofac Surg. 1993. PMID: 8286289 Review.
-
Comparative Analgesic Effects of Ibuprofen, Celecoxib and Tramadol after third Molar Surgery: A Randomized Double Blind Controlled Trial.J Contemp Dent Pract. 2018 Nov 1;19(11):1334-1340. J Contemp Dent Pract. 2018. PMID: 30602637 Clinical Trial.
-
A study of the comparative efficacy of three common analgesics in the control of pain after third molar surgery under local anaesthesia.Aust Dent J. 2002 Dec;47(4):327-30. doi: 10.1111/j.1834-7819.2002.tb00546.x. Aust Dent J. 2002. PMID: 12587769 Clinical Trial.
-
Efficacy of Codeine When Added to Paracetamol (Acetaminophen) and Ibuprofen for Relief of Postoperative Pain After Surgical Removal of Impacted Third Molars: A Double-Blinded Randomized Control Trial.J Oral Maxillofac Surg. 2017 Oct;75(10):2063-2069. doi: 10.1016/j.joms.2017.04.045. Epub 2017 May 15. J Oral Maxillofac Surg. 2017. PMID: 28586638 Clinical Trial.
-
Post-operative sequelae of lower third molar removal: a literature review and pilot study on the effect of Covomycin D.SADJ. 2006 May;61(4):154-9. SADJ. 2006. PMID: 16808181 Review.
Cited by
-
Efficacy of Methylprednisolone Compared to Other Drugs for Pain, Swelling, and Trismus Control after Third Molar Surgery: A Meta-Analysis.Healthcare (Basel). 2022 Jun 1;10(6):1028. doi: 10.3390/healthcare10061028. Healthcare (Basel). 2022. PMID: 35742079 Free PMC article. Review.
-
NSAID chronotherapy after impacted third molar extraction: a randomized controlled trial.Oral Maxillofac Surg. 2022 Dec;26(4):663-672. doi: 10.1007/s10006-021-01029-8. Epub 2022 Jan 22. Oral Maxillofac Surg. 2022. PMID: 35064366 Clinical Trial.
-
Bupivacaine 0.5% versus articaine 4% for the removal of lower third molars. A crossover randomized controlled trial.Med Oral Patol Oral Cir Bucal. 2012 May 1;17(3):e462-8. doi: 10.4317/medoral.17628. Med Oral Patol Oral Cir Bucal. 2012. PMID: 22143739 Free PMC article. Clinical Trial.
-
Efficacy of Submucosal Injection of Chymotrypsin, Oral Serratiopeptidase or Oral Dexamethasone in Reducing Postoperative Complications Following Impacted Lower Third Molar Surgery: A Prospective, Randomized, Double-Blind, Controlled Clinical Trial.Front Oral Health. 2020 Dec 8;1:575176. doi: 10.3389/froh.2020.575176. eCollection 2020. Front Oral Health. 2020. PMID: 35047980 Free PMC article.
-
Effect of low-level laser therapy after extraction of impacted lower third molars.Lasers Med Sci. 2013 May;28(3):845-9. doi: 10.1007/s10103-012-1174-4. Epub 2012 Jul 28. Lasers Med Sci. 2013. PMID: 22843310 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical